Home > Quotes > ELN > Company News

Elan Corporation, plc News Headlines

ELN 
$13.78
*  
0.29
  negative  
2.15%
Get ELN Alerts
*Delayed - data as of Jun. 18, 2013 
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.


Don't know the stock symbol? Use the symbol lookup tool.

Alphabetize the sort order of my symbols 
Symbol Lookup
Log in or Register
 Save stocks for next time
 | Sponsored
Viewing
Filtered By
Ordered By

Stocks End Slightly Lower on Concerns Fed May Taper Off QE
5/20/2013 4:27:00 PM - Knobias

Royalty Pharma Raises Takeover Bid for Elan
5/20/2013 3:15:00 PM - Dow Jones Business News

Royalty Pharma Lifts Elan Bid To $12.50 Per Share - Update
5/20/2013 2:09:00 PM - RTT News

Energy Stocks Lead Markets Modestly Higher at Midday
5/20/2013 1:23:00 PM - Knobias

Royalty Pharma Confirms Increased $12.50/Share Cash Offer For Elan Corp.
5/20/2013 12:19:00 PM - RTT News

Elan Sets Out Deal Plans
5/20/2013 6:15:00 AM - Dow Jones Business News

Elan To Offer $800 Mln Of Senior Notes Due 2021; Announces Several Transactions
5/20/2013 2:28:00 AM - RTT News

The Billion Dollar COPD Deal: Who Gains The Most?
5/17/2013 11:27:00 AM - Seeking Alpha

Complete Seth Klarman And Baupost Group Portfolio Update
5/15/2013 4:46:00 PM - Seeking Alpha

Seth Klarman Buys Warrants, 2 New Stocks
5/15/2013 3:26:48 PM - GuruFocus

Tracking Seth Klarman's Baupost Group Holdings - Q1 2013 Update
5/15/2013 5:33:00 AM - Seeking Alpha

Elan in Royalty Deal with THRX - Analyst Blog
5/14/2013 5:06:44 PM - Zacks.com

Spectrum Pharma Reports 1Q Loss - Analyst Blog
5/14/2013 10:12:01 AM - Zacks.com

ACT, THRX Hit All-time High, NSPH Makes A Big Move, BTX Gets Funding
5/13/2013 10:08:00 PM - RTT News

Elan Strikes $1 Bln Royalty Deal With Theravance
5/13/2013 11:06:00 AM - RTT News

Elan Signs $1 Billion Drug Deal with Theravance
5/13/2013 5:45:00 AM - Dow Jones Business News

Elan Signs $1 Billion Drug Deal
5/13/2013 5:45:00 AM - Dow Jones Business News

Elan, Theravance Enter Into $1.0 Billion Royalty Participation Pact
5/13/2013 2:34:00 AM - Dow Jones Business News

Elan And Theravance Reach $1.0 Bln Royalty Participation Deal - Quick Facts
5/13/2013 2:16:00 AM - RTT News

Dendreon Narrows 1Q Loss - Analyst Blog
5/10/2013 10:49:01 AM - Zacks.com

Positive Data on Forest Combo Drug - Analyst Blog
5/7/2013 4:23:03 PM - Zacks.com

Royalty Pharma Confirms $11.25/shr Offer For Elan
5/2/2013 9:24:00 AM - RTT News

Elan Narrows Y/Y Loss - Analyst Blog
4/25/2013 1:09:01 PM - Zacks.com

UPDATE: Biogen Profits Jump 41%, Stays Mum on Key Drug Launch
4/25/2013 10:37:00 AM - Dow Jones Business News

Biogen 1st-Quarter Net Rose 41% on Higher Multiple-Sclerosis Drugs Sales
4/25/2013 7:19:00 AM - Dow Jones Business News